USPTO serial 86694705
HLS THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 5263254Status 710
- Filing date
- Status date
- Registration date
- Aug 15, 2017
- Examiner
- GUSTASON, ANNE C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with HLS THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan K. Bowen
MEGAN K. BOWEN MORGAN LEWIS BOCKIUS1111 PENNSYLVANIA AVE NWAttn: TMSUWASHINGTON, DC 20004-2578Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular, CNS and other neurological, dermatological, respiratory, gastrointestinal and other metabolic disorders, osteoporosis and other bone disorders, immunomodulatory, ocular, and oncological disorders; and antidepressants, antivirals, antibacterial pharmaceuticals, antifungal preparations, anti-inflammatories, analgesics and other pain therapeutics, namely, pain relief medications, women's health therapeutics, namely, vaginal preparations in the nature of antifungals, pharmaceutical preparations to regulate vaginal ph, pharmaceutical preparations to treat diseases of the genitourinary system in women, hormones, namely, progesterone, progestins, and estrogens, hormone receptor modulators, and osteoporosis medicines | SECTION 8 - CANCELLED | — |
| 042 | Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HLS Therapeutics Inc.
- Other trademarks owned by HLS Therapeutics Inc.
- Other trademarks owned by HLS Therapeutics Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named HLS THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 1, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 15, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 12, 2018 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 22, 2018 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 9, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 9, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 15, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 11, 2017 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| May 11, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 20, 2017 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Apr 20, 2017 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 28, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 3, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 3, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 14, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 29, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 18, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 17, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 17, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 8, 2016 | ALIE | ASSIGNED TO LIE | — |
| Oct 26, 2016 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 28, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 28, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 28, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 12, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 5, 2016 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2015 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 22, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 20, 2015 | NWAP | NEW APPLICATION ENTERED | — |